BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29

• Biotech Bay

  Bay Area Medtech Firm VytronUS Nabs $49 Million Series C

  July 29, 2016

   · 

  4 min read
• Drug Development

  First Patient Enrolled In Mallinckrodt Phase 3 Terlipressin Trial

  July 29, 2016

   · 

  5 min read
• Drug Development

  AbbVie Announces Initiation Of Phase 3 Study Of Venetoclax In Patients With Relapsed Or Refractory Multiple Myeloma

  July 29, 2016

   · 

  9 min read
• Drug Development

  Neurocrine Biosciences Announces Initiation Of A Long-Term Phase II Clinical Study Of VMAT2 Inhibitor Valbenazine In Tourette Syndrome

  July 29, 2016

   · 

  7 min read
• Drug Development

  Quark Pharmaceuticals Inc. Awarded Key Patent For QPI-1007 Ocular Neuroprotectant

  July 29, 2016

   · 

  3 min read
• Business

  Valeant Announces The Addition Of Sarah B. Kavanagh To Its Board Of Directors

  July 29, 2016

   · 

  3 min read
• China Cord Blood Files Its Annual Report On Form 20-F

  July 29, 2016

   · 

  2 min read
• Genetown

  Akcea Therapeutics Receives Orphan Designation In Europe For Volanesorsen For The Treatment Of Familial Partial Lipodystrophy (FPL)

  July 29, 2016

   · 

  7 min read
• Business

  Berg Promotes Coveney To Vice President Of Finance And Controller

  July 29, 2016

   · 

  2 min read
• Business

  Luminex Reports Second Quarter 2016 Results

  July 29, 2016

   · 

  8 min read